3D Bioprinting Market to Grow at 14.52% CAGR by 2018 Forecasts a New Research Report at ReportsnReports.com
Dallas, Texas (PRWEB) September 05, 2014 -- The Global 3D Bioprinting market shows immense potential to grow rapidly in the future, mainly because of the advances in technology of the product. Technological advancements and innovations in the Healthcare industry have resulted in the development of equipment with up-to-date technology that is customized to the needs of patients.
Analysts forecast the Global 3D Bioprinting market to grow at a CAGR of 14.52 percent over the period 2013-2018. According to the report, growing demand from the drug discovery process is one of the major drivers in the market. The use of 3D bioprinting reduces the risk of drug failure during pre-clinical trial testing and minimizes the complications related to human trials.
3D bioprinting is a process to produce tissues in a variety of formats from micro-scale tissues to standard multi-well tissues, where cell function and viability are preserved within the printed construct. A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells. The 3D micro-engineered environments open new channels for drug screening and fundamental studies of wound healing, angiogenesis, and stem-cell niches. Many industries have already benefitted from multiple advancements in this field, resulting in improved and more efficient processes worldwide.
The Global 3D Bioprinting market can be segmented into the technology available in the market: Ink-jet Bioprinters, Valve-based Cell Printers, Laser-assisted Cell Printers, and Magnetic Levitation Bioprinters.
The Global 3D Bioprinting Market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global 3D Bioprinting market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Order a copy of this report at (Prices start at US$2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=297311.
The report recognizes the following companies as the key players in the Global 3D Bioprinting Market: 3D Systems Inc., Envision TEC, Organovo Holdings Inc., Stratasys Inc., Prominent Vendors, 3D Biotek, Advanced Biomatrix, Bespoke Innovations, Digilab, regenHU and Nano3D Biosciences.
Market Driver
- Growing Demand for Drug Discovery Process
- For a full, detailed list, view our report
Market Trend
- Technological Advancements
- For a full, detailed list, view our report
Further, the report states that one of the major challenges in the market is the high price of 3D bioprinting surgeries. The high cost of 3D printing lowers its acceptance among end-users. In addition, there is no healthcare support for 3D printing surgery, which makes it very difficult for many patients to opt for it.
Other New Reports:
Global Advanced Wound Care Market 2014-2018: The report covers the present scenario and the growth prospects of the Global Advanced Wound Care market for the period 2014-2018. To calculate the market size, this report considers the revenue generated from the following three segments:
- Device-based Advanced Wound Care
- Moist Wound Care
- Wound Care Biologics
Global Hepatitis C Market 2014-2018: Analysts forecast the Global Hepatitis C market to grow at a CAGR of 19.20 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Hepatitis C market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through sales of various drugs administered to treat chronic hepatitis caused by genotype 1-6 of hepatitis C virus.
Global Asthma Market 2014-2018: The report covers the present scenario and the growth prospects of the Global Asthma market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various classes of drugs used in the treatment of asthma:
- Bronchodilators
- Leukotriene antagonists
- Mast cell stabilizers
- Immunosuppressants
Explore other new reports by Infiniti Research Limited .
About US
ReportsnReports.com is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email the details on sales(at)reportsandreports(dot)com.
Ritesh Tiwari, Reports and Reports, http://www.reportsnreports.com/, +1 (888) 391-5441, [email protected]
Share this article